Conference Coverage

TAVR shows large survival benefit in diabetes patients

Publish date: September 24, 2013

 

AT THE ESC CONGRESS 2013

The PARTNER trial was sponsored by Edwards Lifesciences, which markets the TAVR device used in the study. Dr. Lindman was an investigator in PARTNER and said that he had no disclosures.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Vitamin C protects kidneys against angiography contrast
MDedge Internal Medicine
Acute onset arthritis possible with clopidogrel
MDedge Internal Medicine
Fruits, not vegetables, seen to lower AAA risk
MDedge Internal Medicine
PCI in noninfarct coronaries helps STEMI patients
MDedge Internal Medicine
Prasugrel pretreatment ups bleeding risk in NSTE ACS
MDedge Internal Medicine
TASTE: Thrombus aspiration has no mortality benefit in STEMI
MDedge Internal Medicine
Registry-based randomized clinical trials are here
MDedge Internal Medicine
On-site bypass rescue unnecessary for primary PCI
MDedge Internal Medicine
High-volume, low-mortality hospitals have lowest postsurgical readmissions
MDedge Internal Medicine
FDA drops access points from Sapien transcatheter valve label
MDedge Internal Medicine